cervical cancer
Conditions
Interventions
Food item: HRB Time period: 7weeks Administration method of a drug: oral uptake Dosage regimen: 3 powders three times a day
Food item: Placebo Time period: 7weeks Administration method of a dru
Sponsors
Department of Radiology, Nagoya University Graduate School of Medicine
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: At study enrollment, patients are required to fulfill all of the following criteria: histologically proven adenocarcinoma, squamous carcinoma, or adenosquamous carcinoma of cervical uterus, WBC>3500/mm3 , ANC>1500/ mm3 , Hb level>=10.0g/dl, Plt>=100000/mm3, T-Bil=<1.5dl, AST and ALT<80IU/L, Cr<1.5mg/dl, CCr>=60ml/min, and provision of written informed consent.
Exclusion criteria
Exclusion criteria: Some of exclusion criteria are as follows: histologically proven small cell carcinoma and sarcoma of cervical uterus, patients planned to be treated with surgery, pregnancy or plans to become pregnant, nursing woman, a past history of allergy to drugs, or ineligibility as determined by the study physicians.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Gastrointestinal disorders Diarrhea Nausea Vomiting | — |
Secondary
| Measure | Time frame |
|---|---|
| Other gastrointestinal disorders | — |
Countries
Japan
Contacts
Public ContactYoshiyuki Itoh
Nagoya University Graduate School of Medicine Therapeutic Radiology
Outcome results
None listed